Does finasteride use affect male fertility or semen parameters in men attempting conception?

Finasteride and Male Fertility

Finasteride should be discontinued in men attempting conception, as it causes reversible reductions in sperm count, semen volume, and potentially sperm DNA integrity, with most parameters normalizing within 3-6 months after cessation. 1, 2

Effects on Semen Parameters

The FDA label explicitly documents that finasteride causes a 22.1% median decrease in ejaculate volume with concomitant reduction in total sperm per ejaculate, though these parameters remain within normal range and are reversible upon discontinuation with an average return to baseline of 84 weeks 1. However, real-world clinical data reveals more concerning impacts:

• 11.6-fold increase in sperm counts after finasteride discontinuation in subfertile men 2
• 57% of men with severe oligospermia (<5 M/mL) improved to >15 M/mL after stopping finasteride 2
• Reductions of 34% in sperm count and 29% in sperm concentration documented in systematic reviews 3
• Significant worsening of total sperm number at 6 months (232.4 vs 133.2 million; p=0.01) 4

The FDA acknowledges postmarketing reports of male infertility and/or poor seminal quality, with normalization or improvement reported after discontinuation 1.

Hormonal Alterations

Finasteride predictably increases testosterone levels (22.1 vs 28.0 ng/mL at 6 months; p<0.05) 4 while reducing DHT by approximately 70%. The 2025 EAU guidelines emphasize that oxidative stress—which finasteride may exacerbate—is associated with sperm DNA damage, reduced DNA integrity, lack of fertilization, poor embryo development, and miscarriage 5.

Critical Timing Considerations

The duration of finasteride use matters significantly:

• Effects appear amplified in subfertile patients 6
• One case report documented elevated sperm DNA fragmentation (30% DFI) that improved to 16.5% within 6 months of cessation 7
• Recovery typically occurs within 3-6 months after discontinuation 2, 6, 7
• The first documented successful pregnancy after long-term use occurred 4 months after cessation 6

For dutasteride (which inhibits both 5α-reductase isoforms), the cutoff for persistent impairment is 17.8 months for semen volume and 20.3 months for sperm motility 8, suggesting combination or prolonged therapy may have more durable effects.

Clinical Algorithm for Men Attempting Conception

1. Immediate discontinuation of finasteride when pregnancy is desired
2. Wait 3-6 months before fertility evaluation to allow parameter normalization
3. Obtain baseline semen analysis at 3 months post-cessation
4. If oligospermia persists, consider sperm DNA fragmentation testing (DFI should be <20%) 7
5. Reassess at 6 months if initial parameters remain abnormal

Important Caveats

The 2025 EAU guidelines note that semen analysis alone cannot distinguish fertile from infertile men 5, but the documented improvements after finasteride cessation are clinically meaningful. While the FDA states effects "remained within normal range" 1, this reflects population averages—individual men, particularly those with baseline subfertility, show dramatic improvements after discontinuation 2.

Sexual function effects are variable and may persist in a subset of patients even after discontinuation 1, 3, though the 2020 study found no sexual dysfunction changes during treatment in andrologically healthy subjects 4.

The independent role of finasteride in reported infertility cases cannot always be established given confounding factors (age, comorbidities, concomitant medications) 1, but the consistent pattern of improvement after cessation across multiple studies supports causality.